$73,935,406

Department of Health and Human Services·National Institutes of Health

ACTION DATE2026-04-24·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75N93021C00014_7529_-NONE-_-NONE-

Award description

MSSM CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE.

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Support NIH Centers of Excellence for Influenza Research and Response at Mount Sinai to advance pandemic preparedness and influenza countermeasures.

Sub-sectors

vaccine-developmentinfluenza-researchnih-research-grant

Why this matters

Strengthens U.S. capacity for rapid influenza vaccine development and pandemic response through a leading academic medical center.

Supply-chain signal

Drives demand for research infrastructure, diagnostic platforms, and vaccine manufacturing capabilities in the biotech supply chain.

U.S.–China competition angle

Positions U.S. biotech leadership in infectious disease research and vaccine innovation against global competitors.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002241.

Period of performance

Start

2021-04-01

End

2028-03-24

Status

activein 678 days

Recipient

Other awards from this recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75N93021C00014_7529_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.